HomeGDTC • NASDAQ
add
CytoMed Therapeutics Ltd
Previous close
$2.23
Day range
$2.25 - $2.25
Year range
$1.20 - $5.50
Market cap
26.29M USD
Avg Volume
17.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (SGD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 112.09K | -21.12% |
Operating expense | 935.96K | -18.88% |
Net income | -544.20K | 49.57% |
Net profit margin | -485.49 | 36.06% |
Earnings per share | — | — |
EBITDA | -741.53K | 18.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SGD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.82M | -34.63% |
Total assets | 10.91M | -21.60% |
Total liabilities | 748.82K | 0.37% |
Total equity | 10.16M | — |
Shares outstanding | 11.54M | — |
Price to book | 2.53 | — |
Return on assets | -18.90% | — |
Return on capital | -19.48% | — |
Cash Flow
Net change in cash
| (SGD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -544.20K | 49.57% |
Cash from operations | -577.94K | 43.16% |
Cash from investing | -943.90K | 65.42% |
Cash from financing | -14.77K | -100.27% |
Net change in cash | -1.50M | -187.87% |
Free cash flow | -890.29K | -60.70% |
About
Founded
2018
Website
Employees
34
